Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

The case for thrombolysis for iliofemoral venous thrombosis. Seminars in vascular surgery Peden, E., Zhou, W., Bush, R. L., Lumsden, A. B., Lin, P. H. 2005; 18 (3): 139-147

Abstract

Deep venous thrombosis and its consequences remain a significant clinical challenge despite advances in the current healthcare system. The use of thrombolytic therapy has played an important role in the management of both arterial and venous thrombotic conditions. In this article, relevant clinical evidence and rationale in support of thrombolytic therapy in ileofemoral deep venous thrombosis are discussed.

View details for PubMedID 16168889